Article Details

Smith+Nephew acquires novel cartilage regeneration technology for sports medicine knee repair

Retrieved on: 2023-11-22 21:02:30

Tags for this article:

Click the tags to see associated articles and topics

Smith+Nephew acquires novel cartilage regeneration technology for sports medicine knee repair. View article details on hiswai:

Excerpt

The U.S. Food and Drug Administration (FDA) granted Agili-C Breakthrough Device designation status in 2020 and Premarket Approval (PMA) in March 2022.

Article found on: orthospinenews.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo